Responses
Other responses
Jump to comment:
- Published on: 18 April 2016
- Published on: 18 April 2016
- Published on: 18 April 2016Reactivation or flare in chronic hepatitis B: need for better definitionsShow More
Dear Editor,
We read with a great interest the article by Hui et al. (1), which is a useful contribution to a better understanding of the mechanisms of hepatitis B virus (HBV) reactivation after withdrawal of preemptive lamivudine in patients with haematological malignancy. We feel, however, that the authors did not provide an exact definition of the term reactivation which is crucial for appropriate...
Conflict of Interest:
None declared. - Published on: 18 April 2016Lamivudine in HBV carriers with malignanciesShow More
Dear Editor,
I read with interest the article by Hui et al. reporting hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with hematological malignancy on completion of cytotoxic chemotherapy.[1] Reactivation of hepatitis B virus (HBV) infection is a well-recognized complication of chemo/immunosuppressive therapy in HBs-Ag positive inactive carriers.[2][3] It occurs in 14% to 50% of such in...
Conflict of Interest:
None declared.